Top 5 Stocks to Buy Now
→ BlackRock's CEO is calling this 'the next major evolution' (From Awesomely, LLC) (Ad)tc pixel Free CRSP Stock Alerts

CRISPR Therapeutics (CRSP) Short Interest Ratio & Short Volume

CRISPR Therapeutics logo
$54.36 +0.27 (+0.50%)
Closing price 04:00 PM Eastern
Extended Trading
$54.30 -0.06 (-0.12%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

CRISPR Therapeutics Short Interest Overview

As of May 29, 2026, CRISPR Therapeutics (CRSP) had a short interest of 21.67 million shares sold short, representing 23.43% of the public float. This marks a -20.60% decrease in short interest since the prior report. The short interest ratio (days to cover) is 12.3, meaning it would take 12.3 days of the average trading volume of 1.56 million shares to cover all short positions.

Current Short Interest
21,672,640 shares
Previous Short Interest
27,293,997 shares
Change Vs. Previous Month
-20.60%
Dollar Volume Sold Short
$1.22 billion
Short Interest Ratio
12.3 Days to Cover
Last Record Date
May 29, 2026
Outstanding Shares
96,450,000 shares
Short Percent of Float
23.43%
Today's Trading Volume
1,128,555 shares
Average Trading Volume
1,560,164 shares
Today's Volume Vs. Average
72%
Short Selling CRISPR Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for CRISPR Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

CRSP Short Interest Over Time

CRSP Days to Cover Over Time

CRSP Percentage of Float Shorted Over Time

CRISPR Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/29/202621,672,640 shares $1.22 billion -20.6%23.4%12.29 $56.10
5/15/202627,293,997 shares $1.32 billion +21.4%29.6%16.54 $48.41
4/30/202622,484,150 shares $1.18 billion -1.2%24.3%11.91 $52.34
4/15/202622,752,661 shares $1.29 billion +0.6%24.7%15.3 $56.76
3/31/202622,618,060 shares $1.08 billion +4.3%24.5%13.23 $47.57
3/13/202621,686,413 shares $1.06 billion +0.6%23.6%7.63 $48.75
2/27/202621,562,457 shares $1.30 billion -4.8%23.4%14.31 $60.14
2/13/202622,638,749 shares $1.20 billion +3.4%24.5%13.21 $53.07
1/30/202621,888,419 shares $1.09 billion +0.7%23.9%12.1 $49.96
1/15/202621,739,501 shares $1.18 billion +3.3%23.8%11.92 $54.12
12/31/202521,051,418 shares $1.10 billion -3.7%23.0%14.19 $52.44
12/15/202521,863,725 shares $1.23 billion -2.5%23.9%12.3 $56.25
11/28/202522,431,985 shares $1.20 billion -3.3%24.5%9.25 $53.63
11/14/202523,186,755 shares $1.22 billion +10.2%25.4%8.57 $52.53
10/31/202521,033,230 shares $1.35 billion -0.1%24.1%9.89 $63.99
10/15/202521,050,000 shares $1.51 billion -1.4%24.1%8.1 $71.82
9/30/202521,350,000 shares $1.38 billion -10.3%N/A7.4 $64.81
9/15/202523,810,000 shares $1.38 billion +7.9%N/A7.6 $57.84
8/31/202522,070,000 shares $1.14 billion -5.3%25.4%7 $51.83
8/15/202523,310,000 shares $1.39 billion -0.6%N/A7.2 $59.73
7/31/202523,450,000 shares $1.32 billion -7.3%26.9%7.5 $56.26
7/15/202525,300,000 shares $1.33 billion -0.9%N/A8.6 $52.73
6/30/202525,540,000 shares $1.24 billion +19.3%30.9%9.4 $48.64
6/15/202521,410,000 shares $885.52 million +4.2%25.9%9.3 $41.36
5/31/202520,540,000 shares $740.26 million -2.5%25.0%9.6 $36.04
5/15/202521,070,000 shares $765.05 million -1.2%25.6%10.5 $36.31
4/30/202521,320,000 shares $824.44 million +2.7%N/A9.4 $38.67
4/15/202520,760,000 shares $808.60 million +1.2%25.2%9.3 $38.95
3/31/202520,510,000 shares $697.96 million +1.0%24.9%9.2 $34.03
3/15/202520,310,000 shares $855.46 million -2.4%24.7%9.7 $42.12
2/28/202520,810,000 shares $913.98 million +2.0%25.3%9.7 $43.92
2/15/202520,410,000 shares $1.01 billion +4.7%24.8%9.5 $49.72
1/31/202519,490,000 shares $810.59 million -4.0%N/A10.1 $41.59
1/15/202520,310,000 shares $792.90 million +6.3%N/A10.8 $39.04
12/31/202419,100,000 shares $751.78 million +5.4%N/A11.4 $39.36
12/15/202418,120,000 shares $793.29 million -0.2%N/A11.6 $43.78
11/30/202418,150,000 shares $928.74 million -6.4%N/A12.7 $51.17
11/15/202419,390,000 shares $916.18 million +4.3%N/A14.8 $47.25
10/31/202418,590,000 shares $862.39 million +5.7%N/A16 $46.39
10/15/202417,590,000 shares $845.20 million +0.2%N/A16.1 $48.05
The Socialists are at the gate (Ad)

Nearly 40% of Americans now hold a positive view of socialism - and former hedge fund manager Whitney Tilson says what's unfolding in New York City is just the beginning. Tilson, a Harvard MBA who spent 30 years on Wall Street, has identified a specific economic pattern he believes points to a financial reset unlike anything seen in over 100 years. He's released a free analysis outlining what's coming and the exact steps he recommends you take with your money now.tc pixel

Read Whitney Tilson's free analysis and protect your wealth today
9/30/202417,560,000 shares $824.97 million +0.1%N/A14.9 $46.98
9/15/202417,540,000 shares $858.41 million +0.6%N/A14.7 $48.94
8/31/202417,440,000 shares $832.24 million +1.6%N/A13.8 $47.72
8/15/202417,170,000 shares $838.75 million +4.5%N/A13.1 $48.85
7/31/202416,430,000 shares $941.27 million +1.9%N/A12 $57.29
7/15/202416,120,000 shares $926.26 million +3.0%N/A12 $57.46
6/30/202415,650,000 shares $845.26 million +5.3%N/A11.9 $54.01
6/15/202414,870,000 shares $945.14 million -5.0%N/A11.1 $63.56
5/31/202415,660,000 shares $841.57 million +2.2%N/A12 $53.74
5/15/202415,330,000 shares $873.20 million +5.1%N/A10.9 $56.96
4/30/202414,590,000 shares $773.12 million -1.0%N/A8.5 $52.99
4/15/202414,740,000 shares $865.53 million -0.1%N/A8.5 $58.72
3/31/202414,760,000 shares $1.01 billion +0.3%N/A7.9 $68.16
3/15/202414,720,000 shares $1.07 billion -2.3%N/A7.4 $72.95
2/29/202415,060,000 shares $1.27 billion +1.3%N/A5.8 $84.22
2/15/202414,870,000 shares $1.26 billion -5.5%N/A5.5 $84.48
1/31/202415,740,000 shares $990.83 million -7.6%N/A5.6 $62.95
1/15/202417,040,000 shares $1.09 billion +4.9%N/A5.8 $64.25
12/31/202316,250,000 shares $1.02 billion -6.2%N/A5.9 $62.60
12/15/202317,330,000 shares $1.08 billion +8.8%N/A6.6 $62.08
11/30/202315,930,000 shares $1.06 billion -2.7%N/A7 $66.73
11/15/202316,370,000 shares $920.49 million +17.9%N/A9.6 $56.23
10/31/202313,890,000 shares $540.74 million +2.5%N/A10.9 $38.93
10/15/202313,550,000 shares $600.40 million +3.9%N/A13.3 $44.31
9/30/202313,040,000 shares $591.89 million -5.4%N/A13.4 $45.39
9/15/202313,790,000 shares $697.50 million -2.1%N/A14.6 $50.58
8/31/202314,080,000 shares $704.14 million +5.0%N/A13.7 $50.01
8/15/202313,410,000 shares $652.80 million +10.7%N/A11.9 $48.68
7/31/202312,110,000 shares $694.27 million -1.6%N/A9.5 $57.33
7/15/202312,310,000 shares $700.56 million -2.1%N/A9.8 $56.91
6/30/202312,570,000 shares $705.68 million +0.8%16.6%9.2 $56.14
6/15/202312,470,000 shares $734.98 million +2.3%16.5%9 $58.94
5/31/202312,190,000 shares $780.65 million -1.9%16.1%9.1 $64.04
5/15/202312,430,000 shares $819.76 million -5.8%16.4%9.5 $65.95
4/30/202313,200,000 shares $646.01 million +1.9%17.5%11.1 $48.94
4/15/202312,950,000 shares $651.51 million +2.0%17.2%11.3 $50.31
3/31/202312,700,000 shares $574.42 million +4.3%16.9%12.2 $45.23
3/15/202312,180,000 shares $547.13 million +9.0%16.2%11.3 $44.92
2/28/202311,170,000 shares $550.90 million +9.0%14.8%10 $49.32
2/15/202310,250,000 shares $534.74 million +2.7%13.7%9.4 $52.17
1/31/20239,980,000 shares $509.18 million +1.0%13.3%9.2 $51.02
1/15/20239,880,000 shares $493.41 million -5.7%13.2%9.1 $49.94
12/30/202210,480,000 shares $426.01 million +12.2%14.0%9.9 $40.65
12/15/20229,340,000 shares $443.65 million -16.2%12.4%8.8 $47.50
11/30/202211,140,000 shares $610.36 million -4.3%14.8%10.6 $54.79
11/15/202211,640,000 shares $710.16 million -7.3%15.5%10.8 $61.01
10/31/202212,550,000 shares $656.87 million +6.7%16.7%11.4 $52.34
10/15/202211,760,000 shares $635.86 million +1.7%15.7%10.4 $54.07
9/30/202211,560,000 shares $755.45 million +5.8%16.1%9.1 $65.35
9/15/202210,930,000 shares $819.86 million +0.5%15.3%7.5 $75.01
A letter from Shannon Stansberry (Ad)

Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel

Watch the full story and see the verified track record for yourself
8/31/202210,880,000 shares $708.18 million +1.5%15.2%6 $65.09
8/15/202210,720,000 shares $859.10 million -2.3%15.0%5.7 $80.14
7/31/202210,970,000 shares $822.75 million -4.9%15.4%5.5 $75.00
7/15/202211,530,000 shares $961.49 million +1.9%16.2%5.8 $83.39
6/30/202211,320,000 shares $687.92 million +6.4%15.9%6.1 $60.77
6/15/202210,640,000 shares $666.70 million +4.0%15.0%6.3 $62.66
5/31/202210,230,000 shares $593.85 million -7.2%14.4%7.3 $58.05
5/15/202211,020,000 shares $575.57 million +8.7%15.5%7.7 $52.23
4/30/202210,140,000 shares $503.15 million -2.3%14.3%7.1 $49.62
4/15/202210,380,000 shares $645.53 million +3.3%14.7%6.8 $62.19
3/31/202210,050,000 shares $630.84 million +7.0%14.2%6.2 $62.77
3/15/20229,390,000 shares $563.78 million +2.5%13.3%5.6 $60.04
2/28/20229,160,000 shares $562.15 million +4.9%13.0%5.5 $61.37
2/15/20228,730,000 shares $532.27 million +6.5%12.4%5.2 $60.97
1/31/20228,200,000 shares $522.75 million -4.0%11.8%5 $63.75
1/15/20228,540,000 shares $578.76 million +6.1%N/A0 $67.77
12/31/20218,050,000 shares $610.03 million -1.2%11.6%4.9 $75.78
12/15/20218,150,000 shares $642.79 million +17.4%11.7%5.1 $78.87
11/30/20216,940,000 shares $554.51 million +18.6%10.0%4.8 $79.90
11/15/20215,850,000 shares $497.72 million +4.8%8.4%4.4 $85.08
10/29/20215,580,000 shares $509.62 million +15.8%8.0%4.4 $91.33
10/15/20214,820,000 shares $467.54 million +80.5%6.9%3.8 $97.00
9/30/20212,670,000 shares $298.85 million -15.8%3.8%2.4 $111.93
9/15/20213,170,000 shares $371.71 million +7.1%4.6%2.6 $117.26
8/31/20212,960,000 shares $369.85 million +0.7%4.4%2.4 $124.95
8/13/20212,940,000 shares $372.67 million +14.0%4.6%2.3 $126.76
7/30/20212,580,000 shares $312.23 million +11.2%4.1%1.9 $121.02
7/15/20212,320,000 shares $294.87 million -28.0%3.6%1.7 $127.10
6/30/20213,220,000 shares $521.29 million -4.2%5.0%2.2 $161.89

CRSP Short Interest - Frequently Asked Questions

Short interest is the volume of CRISPR Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 29th, investors have sold 21,672,640 shares of CRSP short. 23.43% of CRISPR Therapeutics' shares are currently sold short. Learn More on CRISPR Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRSP shares currently have a short interest ratio of 12.3. Learn More on CRISPR Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 23.43% of CRISPR Therapeutics' floating shares are currently sold short.

CRISPR Therapeutics saw a decrease in short interest in the month of May. As of May 29th, there was short interest totaling 21,672,640 shares, a decrease of 20.6% from the previous total of 27,293,997 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

23.43% of CRISPR Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to CRISPR Therapeutics: Allogene Therapeutics, Inc. (14.85%), Axsome Therapeutics, Inc. (7.57%), Beam Therapeutics Inc. (21.68%), Editas Medicine, Inc. (15.88%), Moderna, Inc. (16.33%), Intellia Therapeutics, Inc. (35.83%), Vertex Pharmaceuticals Incorporated (1.77%), Viatris Inc. (3.54%), Genmab A/S Sponsored ADR (1.64%), Ascendis Pharma A/S (4.60%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($81.27 billion), Invesco QQQ ($49.06 billion), iShares Russell 2000 ETF ($23.61 billion), Western Digital Corporation ($16.93 billion), Sandisk Corporation ($15.61 billion), Salesforce Inc. ($11.65 billion), SPDR S&P Biotech ETF ($10.52 billion), Nebius Group N.V. ($10.24 billion), Lumentum Holdings Inc. ($8.74 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($8.21 billion). View all of the most shorted stocks.

Short selling CRSP is an investing strategy that aims to generate trading profit from CRISPR Therapeutics as its price is falling. CRSP shares are trading up $0.48 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for CRISPR Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CRSP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRSP, twice per month. The most recent reporting period available is May, 29 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like CRSP:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:CRSP) was last updated on 6/9/2026 by MarketBeat.com Staff.
From Our Partners
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
But most retirement plans still have gaps in them... The quiet ones that don't show up until it's too late to ...
Money Pickle | Sponsoredtc pixel
I’m shouting ‘Buy Now’ before this stock soars
In 2023, Marc Chaikin's system flagged an automotive stock as bearish - and it fell 35% shortly after. Today, ...
Chaikin Analytics | Sponsoredtc pixel
BlackRock's CEO is calling this "the next major evolution"
Larry Fink, CEO of BlackRock - the world's largest asset manager with $10 trillion under management - is calli...
Awesomely, LLC | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Trump’s secret China deal
Trump just returned from Beijing with the most powerful business delegation in American history - Elon Musk, J...
Porter & Company | Sponsoredtc pixel
Print this before your next trade
Bill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97. It'...
Profits Run | Sponsoredtc pixel